Conference Center
  • ACTRIMS-ECTRIMS 2014┬áHome
  • Day One at ECTRIMS
  • Day Two at ECTRIMS
  • Day Three at ECTRIMS
  • Day Four at ECTRIMS
  • Q&A Panel
  • Overview Article of the Joint ACTRIMS-ECTRIMS Meeting, Boston, MA, Sept. 10-13, 2014

Day Two at ACTRIMS-ECTRIMS

  • What do we know about Alemtuzumab (Lemtrada) Dr. Kantor talks with Dr Alasdair Coles, Neurologist at the University of Cambridge, UK about current information on Alemtuzumab (Lemtrada).
  • Interview with the President of ECTRIMS Dr. Daniel Kantor interviews ECTRIMS President, Professor Maria Trojano of the Neurological and Psychiatric Sciences at the University of Bari, Italy.
  • Phase 1 Stem Cell Trial Dr. Kantor talks with Dr. Jeff Cohen, Director of the Scientific Program Committee of ACTRIMS-ECTRIMS and Director of the Mellan Center at the Cleveland Clinic about a Phase 1 Stem Cell T...
  • Progressive MS Insight and Update Dr Daniel Kantor talks with Dr. Alan Thompson, Professor and Dean of Faculty of the Brain Sciences at the University of College, London about insights and updates on Progressive MS.
  • Research for Progressive MS Dr. Daniel Kantor talks with Dr. David Pitt, Assistant Professor of Neurology at the Yale University School of Medicine about his research on Progressive Multiple Sclerosis.
  • Upper Limbs in MS Dr. Kantor talks with Dr. Francois Bethoux, Director of Rehabilitation Services at the Mellan Center, Cleveland Clinic about Multiple Sclerosis affecting the upper limbs.
  • What is a Phenotype in MS? Dr. Kantor talks with Dr. Tom Scott, Professor of Neurology at Drexel University School of Medicine about Phenotypes.
  • Descriptions about MRI's Dr. Daniel Kantor talks with Research Scientist, Shahmat Syed Tauid from the Partners MS Center in Boston about the descriptions used with MRI's.
  • Diet and MS Study Dr. Daniel Kantor talks with Dr. Yadav, Associate Professor of Neurology at the Oregon Health and Sciences University about a study on Diet and MS.
  • Environmental Factors and MS Dr. Daniel Kantor talks with Dr. Lilyana Amezcua, Assistant Professor of Neurology and Director of the MS Comprehensive Center at ULC about environmental factors and MS.
  • Generic DMT Dr. Daniel Kantor talks with Dr. Jeff Cohen, Director of the Scientific Program Committee of ACTRIMS-ECTRIMS and Director of the Mellan Center at the Cleveland Clinic about a generic form of C...
  • Genetics and MS Dr. Kantor talks with Dr. Alan Jacobs, Clinical Professor of Neurology at Wright State University about genetics and Multiple Sclerosis.
  • Minorities and MS Dr. Kantor talks with Dr. Mitzi Williams, MS Specialist from the Multiple Sclerosis Center of Atlanta about Minorities and MS.
  • New Information about Teriflunomide Dr. Kantor talks with Dr. Mark Freedman, Professor of Medicine Neurology at University Ottawa and Director of MS Research Unit at Ottawa Hospital about new information on Teriflunomide.
WE THANK ALLERGAN, BIOGEN IDEC, EMD SERONO, GENZYME, NOVARTIS, QUESTCOR AND TEVA FOR SUPPORTING MSWORLD'S COVERAGE OF ECTRIMS 2014.
Information shared here is not for the diagnosis or treatment of any medical condition. For specific information and advice, consult your personal physician.